Skip to content

New Fortress Energy NFE Contract novation income

Contract novation income at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$110K-97.5%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$110K-97.5%
CorMedix logo
CorMedixCRMD
$5.51M
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$110K-97.5%
Paycom Software logo
Paycom SoftwarePAYC
$12.9M-5.1%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$3.9M-60.2%

Other financials

Income statement

See full
Revenue$227.0M-51.9%
Gross profit$27.3M-84.0%
Operating income-$225.4M-1,700%
Net income-$400.6M-128%
EPS (diluted)-$1.40-115%

Balance sheet

See full
Cash & equivalents$189.9M-77.3%
Total debt$1.5B-84.8%
Total equity-$180.2M-110%
Total assets$10.4B-20.5%

Cash flow

See full
Operating cash flow-$118.9M-1,543%
CapEx$43.6M-82.9%
Free cash flow-$162.5M+38.1%

Valuation

See full
Market cap$103.71M-84.2%
Enterprise value$1.38B-83.2%
P/S0.1×-0.2×

Profitability

See full
Gross margin35.2%-11.7pp
Operating margin-105.9%-121pp
Net margin-163.4%-194pp
FCF margin-90.1%+73.9pp

Returns & leverage

See full
Return on equity-177.8%-194pp
Debt / equity8.6×+3.7×
Current ratio0.1×-0.9×

Where this comes from

Reported directly by New Fortress Energy in its filing.

Tagged under the XBRL concept nfe:ContractNovationRevenue.

The official record: New Fortress Energy’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about New Fortress Energy's contract novation income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is New Fortress Energy's contract novation income?
New Fortress Energy (NFE) reported contract novation income of $943K in Q1 2026.
How has New Fortress Energy's contract novation income changed year-over-year?
New Fortress Energy's contract novation income decreased by 46.0% year-over-year, from $1.75M to $943K.
What does contract novation income mean?
Income recognized from the transfer of contractual obligations or rights to a third party, effectively replacing an existing contract with a new one. This reflects the company's ability to monetize or restructure its commercial agreements as part of its strategic portfolio management.